Skip to main content

Profile hero

Profile details

About Dr. David Anschütz

David is a corporate/M&A associate and part of our global transactions group.

He advises financial sponsors and corporations on domestic and cross-border M&A transactions as well as on general corporate matters.

David speaks German and English.

Recent work

  • One Equity Partners on the sale of Walki to Oji Holdings Corporation
  • One Equity Partners on the acquisition of Fortaco group from CapMan Buyout
  • International Chemical Investors Group on the sale of Corden Pharma to Astorg
  • Corden Pharma on the acquisition of three production sites from Vifor Pharma
  • Lindsay Goldberg on the sale of PACCOR group to Faerch group
  • One Equity Partners on the sale of Lutech to Apax
  • One Equity Partners on the acquisition of a 29% stake in Cicor Technologies AG from HEB Swiss Investment AG



  • Bucerius Law School, Hamburg, Germany (First State Examination and LL.B.)
  • Sciences Po, Paris, France
  • Ludwig-Maximilians-University, Munich, Germany (Dr. iur.)
  • Legal clerkship (Referendariat) at the Higher Regional Court of Hamburg (Second State Examination)

Professional qualifications

  • Rechtsanwalt, Germany